The genetic defect-adenosine deaminase (ADA) deficiency may be cured permanently by
A. enzyme replacement therapy.
B. administering adenosine deaminase activators.
C. periodic infusion of genetically engineered lymphocytes having functional ADA cDNA.
D. introducing bone marrow cells producing ADA into cells at early embryonic stages.
